<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">42869</article-id><article-id pub-id-type="doi">10.7554/eLife.42869</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Epidemiology and Global Health</subject></subj-group></article-categories><title-group><article-title>Nationally-representative serostudy of dengue in Bangladesh allows generalizable disease burden estimates</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-131075"><name><surname>Salje</surname><given-names>Henrik</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3626-4254</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123834"><name><surname>Paul</surname><given-names>Kishor Kumar</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6054-3571</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123835"><name><surname>Paul</surname><given-names>Repon</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123836"><name><surname>Rodriguez-Barraquer</surname><given-names>Isabel</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6784-1021</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123837"><name><surname>Rahman</surname><given-names>Ziaur</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123838"><name><surname>Alam</surname><given-names>Mohammad Shafiul</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123839"><name><surname>Rahman</surname><given-names>Mahmadur</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123840"><name><surname>Al-Amin</surname><given-names>Hasan Mohammad</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123841"><name><surname>Heffelfinger</surname><given-names>James</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123842"><name><surname>Gurley</surname><given-names>Emily</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8648-9403</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Mathematical Modelling of Infectious Diseases</institution>, <institution>Institut Pasteur</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><aff id="aff2"><institution content-type="dept">Program for Emerging Infections, Infectious Diseases Division</institution>, <institution>icddr,b</institution>, <addr-line><named-content content-type="city">Dhaka</named-content></addr-line>, <country>Bangladesh</country></aff><aff id="aff3"><institution content-type="dept">Department of Medicine</institution>, <institution>University of California, San Francisco</institution>, <addr-line><named-content content-type="city">San Francisco</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution>Institute of Epidemiology, Disease Control and Research</institution>, <addr-line><named-content content-type="city">Dhaka</named-content></addr-line>, <country>Bangladesh</country></aff><aff id="aff5"><institution content-type="dept">Division of Global Health Protection</institution>, <institution>Centers for Disease Control and Prevention</institution>, <addr-line><named-content content-type="city">Atlanta</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">Department of Epidemiology</institution>, <institution>Johns Hopkins Bloomberg School of Public Health</institution>, <addr-line><named-content content-type="city">Baltimore</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-34498"><name><surname>Cooper</surname><given-names>Ben</given-names></name><role>Reviewing editor</role><aff><institution>Mahidol Oxford Tropical Medicine Research Unit</institution>, <country>Thailand</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>hsalje@pasteur.fr</email> (HS);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>08</day><month>04</month><year>2019</year></pub-date><volume>8</volume><elocation-id>e42869</elocation-id><history><date date-type="received"><day>15</day><month>10</month><year>2018</year></date><date date-type="accepted"><day>04</day><month>04</month><year>2019</year></date></history><permissions><license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"><license-p>This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0</ext-link> public domain dedication.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-42869-v1.pdf"/><abstract><p>Serostudies are needed to answer generalizable questions on disease risk. However, recruitment is usually biased by age or location. We present a nationally-representative study for dengue from 70 communities in Bangladesh. We collected data on risk factors, trapped mosquitoes and tested serum for IgG. Out of 5,866 individuals, 24% had evidence of historic infection, ranging from 3% in the north to &gt;80% in Dhaka. Being male (aOR:1.8, [95%CI:1.5-2.0]) and recent travel (aOR:1.3, [1.1-1.8]) were linked to seropositivity. Using catalytic models, we estimate that 40 million [34.3-47.2] people have been infected with 2.4 million ([1.3-4.5]) annual infections. Had we visited only 20 communities, seropositivity estimates would have ranged from 13% to 37%, highlighting the lack of representativeness generated by small numbers of communities. Our findings have implications for both the design of serosurveys and tackling dengue in Bangladesh.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Viruses</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000030</institution-id><institution>Centers for Disease Control and Prevention</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Salje</surname><given-names>Henrik</given-names></name><name><surname>Gurley</surname><given-names>Emily</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: This study was approved by the icddr,b ethical review board. (protocol number PR-14058). The U.S. Centers for Disease Control and Prevention relied on icddr,b's ethical review board approval. All adult participants provided  written, informed consent after receiving detailed explanation of the study and procedures. Parents/guardians of all child participants were asked to provide written, informed consent on their behalf.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files with the exception of precise coordinate information of households.</p></sec><supplementary-material><ext-link xlink:href="elife-42869-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>